PubMed Health⌕ Search

Biomedical subjects

P F Conlon

Publications and source records attributed to P F Conlon.

7 recordsLinked to original sources
PubMed1996

Clinical integration: an interdisciplinary approach to a system priority.

Clinical integration, a Mercy Health Services (MHS) system-wide priority, addresses MHS's ability to provide appropriate, effective clinical care across the continuum and to improve care outcomes. MHS chartered a Clinical Integration Priority Team (CIPT) that developed a common language for clinical integration; began to build infrastructure for coordinated systems of care in such areas as information systems and pharmacy; improved methods and technology for clinical decision making and care delivery; and educated clinicians to improve care processes, manage care for populations, and measure outcomes. Clinical professionals in corporate staff roles have supported clinicians' efforts across the system by providing direction, coaching, educating and supporting in activities to improve patient care.

Continuity of Patient Care↗
PubMed1993

Health center-supplier team approach to solving i.v. equipment problems.

A team approach to problem solving in which a health care center and a supplier worked together to improve product quality is described and a detailed example is provided. When the health care center began using a new supplier for i.v. solutions and equipment, the supplier's incomplete product line and recurrent functional problems with products led to dissatisfaction of staff members. The supplier suggested that the health care center and supplier form a quality action team. The team addressed eight product concerns by using a total quality management process. For each concern, the team defined the problem and formulated a problem statement, collected data and determined the contributing factors to the problem, developed an action plan for solving the problem, and executed the plan and monitored its impact. After the first meeting, the team met monthly to monitor progress and discuss new ways they could work together to improve product quality and reduce costs. The implementation of the action plans allowed the health care center to realize cost savings and increased staff members' satisfaction with the supplier's products. A quality action team, composed of representatives from a health care center and one of its suppliers, used a total quality management process to solve problems to the satisfaction of both sets of participants.

California↗
PubMed1989

Investigational drug practices in Michigan hospitals.

All 188 acute-care hospitals in Michigan with licensed pharmacies were surveyed to assess compliance with recommendations of ASHP, FDA, and the Joint Commission on Accreditation of Healthcare Organizations related to investigational drug use; other practice issues related to investigational drugs but not covered in those guidelines were also studied. Pharmacy directors were questioned about their practices for approving, prescribing, procuring, storing, and labeling investigational drugs; preparation, content, and use of investigational drug data sheets; record keeping; personnel issues; and other investigational drug services provided by the pharmacy department. The response rate was 84.5% (159 completed questionnaires returned), but only 44 respondents (27.7%) indicated that investigational drugs were currently used in their institutions. Written investigational drug policies and procedures were available in 116 (73.0%) of the responding pharmacy departments. Respondents currently handling investigational drugs had high rates of adherence for the following practice guidelines: preparation of data sheets (75.0%), storage (97.7%), monitoring of investigational drug use and stock levels (79.5%), and maintaining perpetual inventories (79.5%). Areas with relatively poor adherence rates included pharmacy department preparation of investigational drug patient-information sheets (20.5%), maintaining information within the pharmacy on minimum stock levels (53.9%), mode of shipment (30.8%), time to receive investigational drugs after order placed (38.5%), acceptance of nursing transcriptions of oral orders (56.8%), including "investigational drug" on the dispensing label (55.8%), and approval of data sheets by the investigator and the institutional review board (40.5% and 37.8%, respectively). Pharmacy departments, regardless of hospital size, should improve their adherence to ASHP, FDA, and Joint Commission guidelines for handling investigational drugs.

Documentation↗
PubMed1983

Implementing guidelines for managing extravasation of antineoplastics.

The development and implementation of guidelines for managing extravasation of antineoplastics in a community teaching hospital are described. Guidelines outlining general and specific treatment measures for extravasation of antineoplastic agents were prepared with the cooperation of the medical, pharmacy, and nursing staffs. These guidelines were incorporated into policies and procedures allowing nurses on the oncology unit to administer i.v. push antineoplastic agents and manage extravasations of these drugs; on other units, physicians were responsible for administering these drugs and managing extravasations. Monographs containing information about administering injectable antineoplastics were compiled in a manual and placed on nursing units as a reference source. An extravasation treatment kit was also prepared by the pharmacy and distributed to the nursing units; kits were exchanged and charged in a manner similar to that used for emergency-code carts. Physicians, nurses, and pharmacists were informed about the extravasation management guidelines and treatment kits through inservice-education programs, newsletters, and staff meetings. A quality-assurance program to monitor process and outcome associated with the use of the guidelines was initiated. Multidisciplinary involvement in the development of extravasation management guidelines for antineoplastic agents used in this hospital ensures prompt and uniform treatment of these adverse reactions.

Antineoplastic Agents↗
PubMed1981

Effect of intravenous furosemide on serum theophylline concentration.

The effect of furosemide on the serum theophylline concentration (STC) was investigated in 10 patients at steady state on a continuous i.v. aminophylline infusion. A baseline STC was obtained 48 hours after the initiation of the maintenance infusion. The patients were monitored closely for the last 24 hours of the maintenance period with hourly flow records to assure the same continuous rate. Urine output was measured over four hours, then, a 40-mg dose of furosemide was administered i.v. over two minutes, and the aminophylline infusion was continued at the same rate. Urine output was measured for four hours after the furosemide dose, and then a second STC was obtained. The 40-mg furosemide i.v. bolus injection caused an average increase of 2.9 micrograms/ml in STC, with a range of 0.5--5.5 micrograms/ml. The urine volumes increased by an average of 995 ml above the baseline, with a range of 630--1377 ml. Both of the increases were significant at the p less than 0.005 level. Patients stabilized on a theophylline dosage regimen should be monitored closely during the addition or discontinuation of furosemide therapy. Furosemide has been shown to be another factor that can alter STC.U

Adult↗